Parallax Volatility Advisers, L.P. Dynavax Technologies Corp Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $739,943 - $947,380	63,243 New	63,243 $784,000
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $156,385 - $313,222	-45,198 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.69 - $4.85 $6,431 - $11,596	2,391 Added 5.59%	45,198 $161,000
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $156,245 - $337,747	42,807 New	42,807 $171,000
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $1,323 - $2,260	-187 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $1,522 - $2,483	187 New	187 $2,000
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $180,913 - $244,272	-15,267 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $117,124 - $160,418	7,731 Added 102.59%	15,267 $233,000
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $26,809 - $36,417	-1,830 Reduced 19.54%	7,536 $150,000
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $162,031 - $225,533	9,366	9,366 $175,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.